Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT05668013. IPD Sharing: YES. Countries: 16. Publications: 0.
The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers
ClinicalTrials.gov study NCT00659646. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
ClinicalTrials.gov study NCT02871570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines
ClinicalTrials.gov study NCT04622254. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
ClinicalTrials.gov study NCT04872101. IPD Sharing: NO. Countries: 7. Publications: 2.
Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00959192. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
ClinicalTrials.gov study NCT00487435. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19
ClinicalTrials.gov study NCT04868903. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01224171. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
ClinicalTrials.gov study NCT04486313. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis
ClinicalTrials.gov study NCT01317797. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT05026177. IPD Sharing: NO. Countries: 4. Publications: 1.
Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00812565. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04551898. IPD Sharing: YES. Countries: 4. Publications: 2.
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
ClinicalTrials.gov study NCT01947491. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
ClinicalTrials.gov study NCT01008410. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Ora
ClinicalTrials.gov study NCT03428100. IPD Sharing: YES. Countries: 14. Publications: 2.
Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19
ClinicalTrials.gov study NCT04805671. IPD Sharing: NO. Countries: 11. Publications: 2.
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01241591. IPD Sharing: Not stated. Countries: 26. Publications: 3.
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
ClinicalTrials.gov study NCT01557166. IPD Sharing: Not stated. Countries: 2. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.